Ricardo Marek is President of Emerging Markets Business Unit (EM BU), and a member of Takeda’s Executive Team, reporting to the Company’s CEO & President, Christophe Weber. Ricardo has over 25 years of experience in various industries and leadership roles. He has been with Takeda for 6 years and over this time he simultaneously held the roles of Area Head for Latin America (LATAM) since 2014, President for Brazil since 2013. Prior to that, he was Chief Financial Officer (CFO) of Brazil. Ricardo led the realignment and restructuring of the LATAM Area, positioning it as one of the top performers across EM BU, and Takeda Brazil as one of the top 10 pharmaceutical companies in the country. He also secured a number of acquisitions as well as launched the Oncology business in the region for Takeda’s potentially life-saving and life-transforming medicines. Ricardo Marek is President of Emerging Markets Business Unit (EM BU), and a member of Takeda’s Executive Team, reporting to the Company’s CEO & President, Christophe Weber. Ricardo has over 25 years of experience in various industries and leadership roles. He has been with Takeda for 6 years and over this time he simultaneously held the roles of Area Head for Latin America (LATAM) since 2014, President for Brazil since 2013. Prior to that, he was Chief Financial Officer (CFO) of Brazil. Ricardo led the realignment and restructuring of the LATAM Area, positioning it as one of the top performers across EM BU, and Takeda Brazil as one of the top 10 pharmaceutical companies in the country. He also secured a number of acquisitions as well as launched the Oncology business in the region for Takeda’s potentially life-saving and life-transforming medicines.

Ricardo Marek is expertise in Oncology business,life-saving and life-transforming medicines.